Private practice with Dr Seth Bilazarian

View all posts »

Physician cost-profiling: Are you "tier 1" or "tier 2"?

May 21, 2010 08:15 EDT


A recent article in New England Journal of Medicine shines light on misclassification of physicians in cost-profile analyses, a practice that is often based on dubious data, erroneous reporting, and misinterpretation of guidelines, which can mislead the public and damage the reputation of the misclassified physician.

Is physician cost-profiling an impossible task? What's your experience with it?

See:

Adams JL, Mehrotra A, et al. Physician cost profiling--reliability and risk of misclassification. N Engl J Med. 2010 Mar 18;362(11):1014-21. Abstract.








Your comments
Physician cost-profiling: Are you "tier 1" or "tier 2"?
# 1 of 3
May 28, 2010 02:25 (EDT)
cindi moore
Thank you for your frank and forthrightness in explaining the misclassification of tier of physician payment.  Your time and energy was very well placed and good for you to take up the cause.
# 2 of 3
June 1, 2010 10:16 (EDT)
Lara
You have experienced what I call the New Face of Medicine.  Your experience was only on a lipid, labs and  medication level.  As an electrophysiologist I refused to implant the cheaper pace makers and defibrillators.  By cheaper I refer to the fact that the hosptial received $2000 more per device from a company that has no little or no follow up outside of Florida.  I was labled an uncooperative physician by the hospital administration.  Unfortunately I was too naive to recognize that nursing staff was coherced into supporting the hospital, the result was a one way valve for a chest tube placed the wrong way, positive troponins not reported to me, a patient with a heart rate of 38bpm hospitalized on a medicine ward instead of CCU despite a written order for CCU, the list goes on and on.    This is The New Face of Medicine--I have left that hospital but would like to know how I could have defended myself and more importantly the patients in this horrendous situation?
# 3 of 3
June 5, 2010 06:48 (EDT)
Norman

Physicians have been absent without leave when it comes to their participation in the processes that are shaping our profession whether it be locally in the hospital setting or in our state capitals or in Washington DC.  Just think about all of those hospital committee meetings you did not have time to attend and lend your voice or all of those elections that we have not supported financially candidates who were medicine friendly or modify the views of those who are not so friendly.  We all know in politics that money talks.  This power vacuum has now been filled by physician unfriendly administrators and bureaucrats. What we do well is whine after the fact. How much money have you given to a physician friendly congressional campaign? How many times have you gone with the ACC to meet your congressional representatives in D.C.? Was the potential loss of two days of practice revenue and cost of an airline ticket and two nights in a hotel worth the 30% cut we in revenue we took in January and the pending 21% cut we may see in less then two weeks? I bet that is going to cost you six figures plus every single year that you have left in practice. And worse it will have a detrimental effect on how we can take care of our patients, something we have dedicated our lives to. Have you been waiting for someone else to do the heavy lifting so you can see one more patient in the office, do one more procedure in the cath lab or get home a little early for that shot shot of Scotch after a tough day?

This has been the result of a failure of both physician leadership and the individual physicians. Why did it take the ACC leadership so long to integrate the political process into their annual scientific sessions? Even now, it is a marginal part of the meetings. Didn't they know that how we practice in the future was going to be impacted more by what goes on in Washington DC then all of the late breaking clinical trial presentations combined. Why does the AHA not even participate at all in the political process that is bringing medicine to its knees? Does tradition win over necessity? Where is the passion in our leadership?  Are we supposed to be proud of the fact that we did all we could by sending some silly emails to our congressional representatives? Worse yet, I bet most of us have not even hit the keys on our computers to even do that.  And this is what our adversaries are counting on and so far that is one expectation we have been able to live up to.  And whether we work in an academic center, staff physician or in private practice the implications are the same. We will not be in control of our destiny.


You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.

Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.

Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:

  • Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
  • Practice approaches to the extra clinical issues in dealing with managed care insurers
  • Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
  • Experiences with restrictions on testing and imaging
The video blog (VLOG) will provide an opportunity to share broadly different approaches to the common conundrums we face in caring for patients. My hope is that this forum will provide useful data points for practice outside of tertiary and academic centers and a look inside community hospitals and physician?s practice patterns in the office, starting with mine.